Meeshanthini Dogan
Amministratore Delegato presso CARDIO DIAGNOSTICS HOLDINGS, INC.
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Meeshanthini V.
Dogan is the founder of Cardio Diagnostics, Inc. which was founded in 2017.
She holds the title of Chief Executive Officer & Director at the company.
Currently, she is also the Chief Executive Officer & Director at Cardio Diagnostics Holdings, Inc. since 2022.
Dr. Dogan has an education background from the University of Iowa, with degrees in undergraduate, graduate, and doctorate studies.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2024 | 1 586 464 ( 6.99% ) | 1 M $ | 31/05/2024 |
Posizioni attive di Meeshanthini Dogan
| Società | Posizione | Inizio |
|---|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Amministratore Delegato | 25/10/2022 |
Cardio Diagnostics, Inc.
 Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Fondatore | 01/05/2017 |
Formazione di Meeshanthini Dogan
| University of Iowa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
- Borsa valori
- Insiders
- Meeshanthini Dogan
